Literature DB >> 25778391

The distribution of pathogenic and toxigenic genes among MRSA and MSSA clinical isolates.

Abbas Ali Imani Fooladi1, Elnaz Ashrafi2, Shafie Gorbani Tazandareh3, Roohollah Zarei Koosha4, Hamid Sedighian Rad1, Mohsen Amin5, Mina Soori3, Reza Abbasi Larki6, Ali Choopani7, Hamideh Mahmoodzadeh Hosseini8.   

Abstract

Staphylococcus aureus (S. aureus) is considered as a notorious nosocomial pathogen among hospitalized patients and community-dwelling subjects. Its increasing morbidity and mortality is believed to be due to antibiotic resistance. However, the data concerning molecular properties of infecting strains are few. In this study, a total of 192 S. aureus strains, including 88 (45.8%) meticillin-sensitive S. aureus (MSSA) and 104 (54.2%) meticillin-resistant S. aureus (MRSA) were recovered from clinical samples. The prevalence of subtypes containing staphylococcal cassette chromosome mec (SSCmec), staphylococcal enterotoxins (SEs), toxic shock syndrome toxin (TSST) and exfoliative toxin was assessed by PCR. Antibiotic susceptibility pattern and vancomycin resistance of each isolate were evaluated by disk diffusion method and micro-dilution method, respectively. 9 (2.3%) strains required MIC > 2 mg/l of vancomycin, which significantly increased among multi drug resistant (MDR), MRSA and SCCmec type III strains (p < 0.05). 171 (89%), 140 (72.91%), 7 (3.6), 78 (48.6%), 5 (2.6%), 151 (78.64%), 129 (67.18%), 178 (92.7%) and 15 (7.8%) of 192 isolates harbored mecA, entA, entB, entC, entD, entE, eta, etb and tsst-1 genes, respectively. 31 (16.14%), 5 (2.6%), 95 (49.48%) and 7 (3.64%) of 192 isolates carried SCCmec type I, II, III and IV, respectively. We found a significantly higher rate of MRSA and resistance to all tested antibiotics, except to penicillin G, kanamycin and linezolide among the SCCmec type III class (p < 0.05). According to our findings, MSSA isolates should be taken as seriously as MRSA strains due to the potential presence of broad spectrum virulence factor genes.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Entorotoxin; MRSA; MSSA; SCCmec; Staphylococcus aureus; Superantigen

Mesh:

Substances:

Year:  2015        PMID: 25778391     DOI: 10.1016/j.micpath.2015.03.013

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  14 in total

Review 1.  Emerging role of nanomedicine in the treatment of neuropathic pain.

Authors:  Pankaj Bidve; Namrata Prajapati; Kiran Kalia; Rakesh Tekade; Vinod Tiwari
Journal:  J Drug Target       Date:  2019-07-22       Impact factor: 5.121

2.  Carriage of the Toxic Shock Syndrome Toxin Gene by Contemporary Community-Associated Staphylococcus aureus Isolates.

Authors:  Katelyn L Parrish; Kristine M Wylie; Patrick J Reich; Patrick G Hogan; Todd N Wylie; Colleen R Kennedy; William Lainhart; David A Hunstad; Carey-Ann D Burnham; Stephanie A Fritz
Journal:  J Pediatric Infect Dis Soc       Date:  2019-11-06       Impact factor: 3.164

3.  Role of Bioaerosols on the Short-Distance Transmission of Multidrug-Resistant Methicillin-Resistant Staphylococcus aureus (MRSA) in a Chicken Farm Environment.

Authors:  Bing-Mu Hsu; Jung-Sheng Chen; Gwo-Jong Hsu; Suprokash Koner; Viji Nagarajan; Hsin-Chi Tsai
Journal:  Antibiotics (Basel)       Date:  2022-01-10

Review 4.  Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment.

Authors:  Ali Hassoun; Peter K Linden; Bruce Friedman
Journal:  Crit Care       Date:  2017-08-14       Impact factor: 9.097

5.  Characterisation of antibiotic resistance, virulence, clonality and mortality in MRSA and MSSA bloodstream infections at a tertiary-level hospital in Hungary: a 6-year retrospective study.

Authors:  Andrea Horváth; Orsolya Dobay; Judit Sahin-Tóth; Emese Juhász; Júlia Pongrácz; Miklós Iván; Enikő Fazakas; Katalin Kristóf
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-05-07       Impact factor: 3.944

6.  A molecular epidemiological study of methicillin-resistant and methicillin-susceptible Staphylococcus aureus contamination in the airport environment.

Authors:  Zhiyao Chen; Changlin Han; Xiaobin Huang; Yangqun Liu; Dan Guo; Xiaohua Ye
Journal:  Infect Drug Resist       Date:  2018-11-20       Impact factor: 4.003

7.  Nasal and extra nasal MRSA colonization in hemodialysis patients of north-west of Iran.

Authors:  Fatemeh Ravanbakhsh Ghavghani; Leila Rahbarnia; Behrooz Naghili; Alireza Dehnad; Ahad Bazmani; Mojtaba Varshochi; Mohammad Hossein Ghaffari Agdam
Journal:  BMC Res Notes       Date:  2019-05-10

Review 8.  CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia.

Authors:  Xiaohong Xiang; Keli Qian; Zhen Zhang; Fengyun Lin; Yang Xie; Yang Liu; Zongfa Yang
Journal:  J Drug Target       Date:  2020-05-26       Impact factor: 5.121

9.  Occurrence, distribution and pattern analysis of methicillin resistant (MRSA) and methicillin sensitive (MSSA) Staphylococcus aureus on fomites in public facilities.

Authors:  Ziad W Jaradat; Maysoon Khwaileh; Waseem Al Mousa; Qutaiba O Ababneh; Anas Al Nabulsi
Journal:  Pathog Glob Health       Date:  2021-08-02       Impact factor: 3.735

Review 10.  The applications of CRISPR/Cas system in molecular detection.

Authors:  Li Zhou; Rongxue Peng; Rui Zhang; Jinming Li
Journal:  J Cell Mol Med       Date:  2018-10-19       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.